Details for: FOXO1

Gene ID: 2308

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: FOXO1

Ensembl ID: ENSG00000150907

Description: forkhead box O1

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • adipocyte CL0000136
    CSI 70.71
    rCSI 90.79%
    PRS 36.24
  • cardiac neuron CL0010022
    CSI 30.4
    rCSI 97.27%
    PRS 36.81
  • sncg GABAergic cortical interneuron CL4023015
    CSI 27.64
    rCSI 44.46%
    PRS 27.78
  • epicardial adipocyte CL1000309
    CSI 23.54
    rCSI 76.61%
    PRS 42.32
  • astrocyte of the cerebral cortex CL0002605
    CSI 22.2
    rCSI 49.77%
    PRS 26.35
  • chondrocyte CL0000138
    CSI 21.42
    rCSI 34.06%
    PRS 33.66
  • cerebral cortex endothelial cell CL1001602
    CSI 20.98
    rCSI 36.29%
    PRS 31.31
  • sst GABAergic cortical interneuron CL4023017
    CSI 20.49
    rCSI 26.41%
    PRS 26.67
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 19.47
    rCSI 13.12%
    PRS 49.02
  • pulmonary capillary endothelial cell CL4028001
    CSI 19.15
    rCSI 36.53%
    PRS 56.09
  • choroid plexus epithelial cell CL0000706
    CSI 18.81
    rCSI 30.8%
    PRS 31.46
  • immature B cell CL0000816
    CSI 18.09
    rCSI 13.44%
    PRS 52.14
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 15.58
    rCSI 26.15%
    PRS 25.78
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 14.82
    rCSI 10.41%
    PRS 63.16
  • ionocyte CL0005006
    CSI 13.98
    rCSI 14.99%
    PRS 37.57
  • alveolar type 1 fibroblast cell CL4028004
    CSI 13.34
    rCSI 14.61%
    PRS 43.42
  • endothelial cell of pericentral hepatic sinusoid CL0019022
    CSI 13.32
    rCSI 41.03%
    PRS 51.64
  • ciliated epithelial cell CL0000067
    CSI 13.28
    rCSI 11.68%
    PRS 29.97
  • stromal cell of ovary CL0002132
    CSI 13.06
    rCSI 35.88%
    PRS 55.29
  • mature T cell CL0002419
    CSI 13.06
    rCSI 10.15%
    PRS 55.57
  • hepatic stellate cell CL0000632
    CSI 12.94
    rCSI 48.48%
    PRS 33.79
  • naive B cell CL0000788
    CSI 11.76
    rCSI 10.09%
    PRS 48.92
  • cardiac muscle cell CL0000746
    CSI 11.36
    rCSI 16.3%
    PRS 32.09
  • renal principal cell CL0005009
    CSI 10.81
    rCSI 28.09%
    PRS 45.28
  • epithelial cell of proximal tubule CL0002306
    CSI 10.38
    rCSI 25.34%
    PRS 36.42
  • subcutaneous adipocyte CL0002521
    CSI 10.12
    rCSI 51.81%
    PRS 43.01
  • enteroglial cell CL4040002
    CSI 10.01
    rCSI 52.63%
    PRS 49.33
  • Kupffer cell CL0000091
    CSI 9.93
    rCSI 22.71%
    PRS 39.12
  • endothelial cell of placenta CL0009092
    CSI 9.93
    rCSI 48.93%
    PRS 50.86
  • alveolar adventitial fibroblast CL4028006
    CSI 9.9
    rCSI 15.64%
    PRS 40.58
  • renal beta-intercalated cell CL0002201
    CSI 9.36
    rCSI 22.31%
    PRS 42.24
  • midzonal region hepatocyte CL0019028
    CSI 8.97
    rCSI 21.05%
    PRS 49.14
  • renal alpha-intercalated cell CL0005011
    CSI 8.86
    rCSI 11.85%
    PRS 47.58
  • double negative thymocyte CL0002489
    CSI 8.86
    rCSI 6.16%
    PRS 47.49
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 8.67
    rCSI 15.32%
    PRS 24.87
  • myofibroblast cell CL0000186
    CSI 8.49
    rCSI 11.75%
    PRS 45.38
  • T follicular helper cell CL0002038
    CSI 8.33
    rCSI 6.23%
    PRS 53.76
  • keratocyte CL0002363
    CSI 8.25
    rCSI 19.84%
    PRS 50.11
  • naive T cell CL0000898
    CSI 7.93
    rCSI 5.52%
    PRS 51.93
  • Mueller cell CL0000636
    CSI 7.92
    rCSI 18.08%
    PRS 34.07
  • endocardial cell CL0002350
    CSI 7.67
    rCSI 36.71%
    PRS 41.74
  • pro-B cell CL0000826
    CSI 7.66
    rCSI 6.34%
    PRS 40.5
  • cardiac blood vessel endothelial cell CL0010006
    CSI 7.49
    rCSI 52.99%
    PRS 35.04
  • alpha-beta T cell CL0000789
    CSI 7.43
    rCSI 8.71%
    PRS 54.3
  • fibroblast of lung CL0002553
    CSI 7.38
    rCSI 6.87%
    PRS 39.48
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 7.35
    rCSI 5.28%
    PRS 51.81
  • skin fibroblast CL0002620
    CSI 7.17
    rCSI 6.18%
    PRS 49.06
  • hepatocyte CL0000182
    CSI 7.14
    rCSI 12.78%
    PRS 38.11
  • group 3 innate lymphoid cell CL0001071
    CSI 6.85
    rCSI 5.15%
    PRS 42.62
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 6.79
    rCSI 6.67%
    PRS 54.45
  • fibroblast of cardiac tissue CL0002548
    CSI 6.77
    rCSI 32.46%
    PRS 37.89
  • precursor B cell CL0000817
    CSI 6.7
    rCSI 5.87%
    PRS 49.08
  • CD14-positive monocyte CL0001054
    CSI 6.7
    rCSI 8.34%
    PRS 50.58
  • lung secretory cell CL1000272
    CSI 6.22
    rCSI 15.4%
    PRS 37.79
  • innate lymphoid cell CL0001065
    CSI 6.05
    rCSI 12.5%
    PRS 46.97
  • mucosal invariant T cell CL0000940
    CSI 5.88
    rCSI 4.75%
    PRS 50.78
  • VIP GABAergic cortical interneuron CL4023016
    CSI 5.87
    rCSI 7.02%
    PRS 25.74
  • blood vessel endothelial cell CL0000071
    CSI 5.68
    rCSI 11.79%
    PRS 38.02
  • centrilobular region hepatocyte CL0019029
    CSI 5.61
    rCSI 14.65%
    PRS 48.71
  • inhibitory interneuron CL0000498
    CSI 5.57
    rCSI 12.86%
    PRS 32.64
  • parietal epithelial cell CL1000452
    CSI 5.47
    rCSI 14.62%
    PRS 33.55
  • podocyte CL0000653
    CSI 5.25
    rCSI 23.34%
    PRS 38.22
  • epithelial cell of lower respiratory tract CL0002632
    CSI 5.23
    rCSI 4.06%
    PRS 39.79
  • periportal region hepatocyte CL0019026
    CSI 5.13
    rCSI 19.95%
    PRS 48.93
  • kidney interstitial fibroblast CL1000692
    CSI 5.11
    rCSI 27.14%
    PRS 41
  • Schwann cell CL0002573
    CSI 5.03
    rCSI 14.29%
    PRS 39.86
  • vascular leptomeningeal cell CL4023051
    CSI 4.91
    rCSI 8.61%
    PRS 32.77
  • mesothelial cell CL0000077
    CSI 4.86
    rCSI 19%
    PRS 18.53
  • endothelial cell of vascular tree CL0002139
    CSI 4.77
    rCSI 26.06%
    PRS 44.14
  • retinal blood vessel endothelial cell CL0002585
    CSI 4.74
    rCSI 7.56%
    PRS 42.96
  • kidney connecting tubule epithelial cell CL1000768
    CSI 4.72
    rCSI 11.97%
    PRS 31.31
  • goblet cell CL0000160
    CSI 4.52
    rCSI 4.27%
    PRS 40.82
  • brush cell of tracheobronchial tree CL0002075
    CSI 4.43
    rCSI 13.15%
    PRS 50.98
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 4.4
    rCSI 10.69%
    PRS 25
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 4.4
    rCSI 11.46%
    PRS 38.8
  • vascular associated smooth muscle cell CL0000359
    CSI 4.36
    rCSI 14.15%
    PRS 43.09
  • intermediate monocyte CL0002393
    CSI 4.32
    rCSI 6.51%
    PRS 41.2
  • stem cell CL0000034
    CSI 4.24
    rCSI 4.09%
    PRS 31.19
  • retinal rod cell CL0000604
    CSI 4.18
    rCSI 7.36%
    PRS 38.54
  • adventitial cell CL0002503
    CSI 4.17
    rCSI 9.96%
    PRS 50.75
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 4.16
    rCSI 10.77%
    PRS 36.3
  • type B pancreatic cell CL0000169
    CSI 4.15
    rCSI 9.19%
    PRS 36.99
  • alveolar macrophage CL0000583
    CSI 4.02
    rCSI 6.63%
    PRS 44.77
  • kidney collecting duct principal cell CL1001431
    CSI 3.99
    rCSI 20.07%
    PRS 50.72
  • type EC enteroendocrine cell CL0000577
    CSI 3.9
    rCSI 13.84%
    PRS 53.13
  • cholangiocyte CL1000488
    CSI 3.66
    rCSI 21.96%
    PRS 54.75
  • perivascular cell CL4033054
    CSI 3.66
    rCSI 5%
    PRS 44.18
  • mononuclear phagocyte CL0000113
    CSI 3.57
    rCSI 7.86%
    PRS 43.41
  • pancreatic A cell CL0000171
    CSI 3.5
    rCSI 3.67%
    PRS 42.03
  • elicited macrophage CL0000861
    CSI 3.5
    rCSI 3.21%
    PRS 46.49
  • late pro-B cell CL0002048
    CSI 3.46
    rCSI 8.66%
    PRS 70.71
  • glandular epithelial cell CL0000150
    CSI 3.45
    rCSI 9.08%
    PRS 62.66
  • intestine goblet cell CL0019031
    CSI 3.32
    rCSI 2.94%
    PRS 38.91
  • T-helper 17 cell CL0000899
    CSI 3.29
    rCSI 2.61%
    PRS 61.01
  • lung pericyte CL0009089
    CSI 3.13
    rCSI 8.27%
    PRS 46.59
  • regulatory T cell CL0000815
    CSI 3.12
    rCSI 3.62%
    PRS 63.42
  • squamous epithelial cell CL0000076
    CSI 3.09
    rCSI 7.34%
    PRS 45.36
  • renal interstitial pericyte CL1001318
    CSI 3.09
    rCSI 8.51%
    PRS 36.89
  • respiratory basal cell CL0002633
    CSI 3.08
    rCSI 3.19%
    PRS 45.13
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 3.03
    rCSI 4.3%
    PRS 37.07
  • pancreatic stellate cell CL0002410
    CSI 0.3
    rCSI 1.9%
    PRS 50.8%
  • bronchiolar smooth muscle cell CL4033017
    CSI 0.3
    rCSI 5.1%
    PRS 66.0%
  • vein endothelial cell of respiratory system CL4033008
    CSI 0.4
    rCSI 2.7%
    PRS 58.7%
  • regular ventricular cardiac myocyte CL0002131
    CSI 0.4
    rCSI 2.4%
    PRS 33.1%
  • pancreatic acinar cell CL0002064
    CSI 0.5
    rCSI 0.7%
    PRS 43.9%
  • extravillous trophoblast CL0008036
    CSI 0.5
    rCSI 0.6%
    PRS 35.7%
  • central nervous system neuron CL2000029
    CSI 0.5
    rCSI 3.9%
    PRS 28.9%
  • kidney distal convoluted tubule epithelial cell CL1000849
    CSI 0.6
    rCSI 6.7%
    PRS 41.9%
  • colon macrophage CL0009038
    CSI 0.6
    rCSI 2.9%
    PRS 62.6%
  • enterocyte of epithelium of large intestine CL0002071
    CSI 0.7
    rCSI 3.4%
    PRS 54.9%
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 0.7
    rCSI 1.2%
    PRS 63.6%
  • Hofbauer cell CL3000001
    CSI 0.8
    rCSI 1.4%
    PRS 49.0%
  • endothelial cell of uterus CL0009095
    CSI 0.8
    rCSI 5.6%
    PRS 67.0%
  • smooth muscle cell of the pulmonary artery CL0002591
    CSI 0.8
    rCSI 5.8%
    PRS 60.2%
  • endothelial cell of arteriole CL1000412
    CSI 0.8
    rCSI 4.6%
    PRS 64.4%
  • L4 intratelencephalic projecting glutamatergic neuron CL4030063
    CSI 0.9
    rCSI 2.1%
    PRS 30.3%
  • blood vessel smooth muscle cell CL0019018
    CSI 0.9
    rCSI 7.2%
    PRS 35.2%
  • pancreatic PP cell CL0002275
    CSI 0.9
    rCSI 3.7%
    PRS 55.4%
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 1.0
    rCSI 3.4%
    PRS 24.7%
  • tissue-resident macrophage CL0000864
    CSI 1.0
    rCSI 4.5%
    PRS 59.7%
  • regular atrial cardiac myocyte CL0002129
    CSI 1.0
    rCSI 3.2%
    PRS 39.4%
  • S cone cell CL0003050
    CSI 1.1
    rCSI 4.6%
    PRS 37.2%
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 1.1
    rCSI 2.4%
    PRS 38.6%
  • OFFx cell CL4033036
    CSI 1.1
    rCSI 5.0%
    PRS 38.1%
  • corneal epithelial cell CL0000575
    CSI 1.1
    rCSI 3.2%
    PRS 57.4%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.2
    rCSI 1.4%
    PRS 46.6%
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 1.2
    rCSI 3.0%
    PRS 70.9%
  • kidney loop of Henle thick ascending limb epithelial cell CL1001106
    CSI 1.2
    rCSI 10.2%
    PRS 42.3%
  • helper T cell CL0000912
    CSI 1.2
    rCSI 1.7%
    PRS 49.0%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 1.2
    rCSI 3.8%
    PRS 28.9%
  • pancreatic D cell CL0000173
    CSI 1.2
    rCSI 1.2%
    PRS 41.9%
  • muscle cell CL0000187
    CSI 1.2
    rCSI 2.5%
    PRS 62.2%
  • lung ciliated cell CL1000271
    CSI 1.2
    rCSI 1.4%
    PRS 30.7%
  • H2 horizontal cell CL0004218
    CSI 1.2
    rCSI 6.1%
    PRS 40.0%
  • Bergmann glial cell CL0000644
    CSI 1.3
    rCSI 1.7%
    PRS 37.0%
  • myeloid dendritic cell CL0000782
    CSI 1.3
    rCSI 1.9%
    PRS 55.2%
  • dendritic cell, human CL0001056
    CSI 1.3
    rCSI 2.1%
    PRS 46.1%
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 1.4
    rCSI 2.5%
    PRS 34.3%
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 1.4
    rCSI 3.8%
    PRS 48.4%
  • uterine smooth muscle cell CL0002601
    CSI 1.4
    rCSI 9.5%
    PRS 77.0%
  • GABAergic neuron CL0000617
    CSI 1.5
    rCSI 4.9%
    PRS 29.6%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 1.5
    rCSI 4.3%
    PRS 56.3%
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 1.5
    rCSI 1.4%
    PRS 54.2%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.6
    rCSI 1.2%
    PRS 38.2%
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 1.6
    rCSI 1.6%
    PRS 68.1%
  • lung macrophage CL1001603
    CSI 1.6
    rCSI 3.6%
    PRS 45.6%
  • plasmablast CL0000980
    CSI 1.6
    rCSI 1.3%
    PRS 45.6%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 1.6
    rCSI 6.4%
    PRS 59.3%
  • fast muscle cell CL0000190
    CSI 1.6
    rCSI 6.4%
    PRS 52.4%
  • pancreatic ductal cell CL0002079
    CSI 1.7
    rCSI 3.2%
    PRS 41.4%
  • respiratory suprabasal cell CL4033048
    CSI 1.7
    rCSI 2.2%
    PRS 44.2%
  • mesenchymal stem cell of adipose tissue CL0002570
    CSI 1.7
    rCSI 9.4%
    PRS 60.2%
  • endothelial cell of periportal hepatic sinusoid CL0019021
    CSI 1.7
    rCSI 7.8%
    PRS 60.4%
  • keratinocyte CL0000312
    CSI 1.7
    rCSI 1.5%
    PRS 44.8%
  • skeletal muscle satellite stem cell CL0008011
    CSI 1.8
    rCSI 7.9%
    PRS 65.2%
  • basophil CL0000767
    CSI 1.8
    rCSI 3.9%
    PRS 60.9%
  • intrahepatic cholangiocyte CL0002538
    CSI 1.9
    rCSI 4.6%
    PRS 56.2%
  • CD4-positive helper T cell CL0000492
    CSI 2.0
    rCSI 1.5%
    PRS 51.2%
  • IgG plasma cell CL0000985
    CSI 2.0
    rCSI 2.4%
    PRS 58.2%
  • endothelial cell of lymphatic vessel CL0002138
    CSI 2.0
    rCSI 4.0%
    PRS 64.8%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 2.0
    rCSI 3.4%
    PRS 60.3%
  • colon epithelial cell CL0011108
    CSI 2.0
    rCSI 2.1%
    PRS 37.2%
  • lung endothelial cell CL1001567
    CSI 2.1
    rCSI 4.8%
    PRS 66.1%
  • retinal pigment epithelial cell CL0002586
    CSI 2.2
    rCSI 4.3%
    PRS 39.5%
  • myoepithelial cell CL0000185
    CSI 2.3
    rCSI 5.7%
    PRS 47.4%
  • retinal bipolar neuron CL0000748
    CSI 2.4
    rCSI 4.5%
    PRS 30.6%
  • granulocyte CL0000094
    CSI 2.4
    rCSI 3.7%
    PRS 48.3%
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 2.4
    rCSI 2.3%
    PRS 59.8%
  • BEST4+ enteroycte CL4030026
    CSI 2.5
    rCSI 3.1%
    PRS 42.1%
  • pulmonary artery endothelial cell CL1001568
    CSI 2.5
    rCSI 3.4%
    PRS 52.2%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 2.5
    rCSI 1.5%
    PRS 53.5%
  • kidney collecting duct intercalated cell CL1001432
    CSI 2.5
    rCSI 18.1%
    PRS 46.5%
  • retinal cone cell CL0000573
    CSI 2.6
    rCSI 4.1%
    PRS 31.5%
  • small pre-B-II cell CL0000954
    CSI 2.6
    rCSI 2.5%
    PRS 63.4%
  • melanocyte CL0000148
    CSI 2.6
    rCSI 1.9%
    PRS 34.0%
  • cardiac endothelial cell CL0010008
    CSI 2.6
    rCSI 10.6%
    PRS 38.4%
  • stromal cell CL0000499
    CSI 2.7
    rCSI 7.5%
    PRS 41.2%
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 2.7
    rCSI 3.6%
    PRS 52.4%
  • pulmonary alveolar type 2 cell CL0002063
    CSI 2.8
    rCSI 4.3%
    PRS 49.8%
  • duct epithelial cell CL0000068
    CSI 2.8
    rCSI 4.1%
    PRS 42.4%
  • conjunctival epithelial cell CL1000432
    CSI 2.8
    rCSI 4.3%
    PRS 40.2%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 2.8
    rCSI 5.6%
    PRS 57.5%
  • bronchus fibroblast of lung CL2000093
    CSI 2.8
    rCSI 2.3%
    PRS 40.6%
  • neural crest cell CL0011012
    CSI 2.9
    rCSI 2.3%
    PRS 28.7%
  • mature B cell CL0000785
    CSI 2.9
    rCSI 2.5%
    PRS 48.1%
  • indirect pathway medium spiny neuron CL4023029
    CSI 2.9
    rCSI 70.4%
    PRS 26.1%
  • contractile cell CL0000183
    CSI 2.9
    rCSI 8.7%
    PRS 38.3%
  • direct pathway medium spiny neuron CL4023026
    CSI 3.0
    rCSI 70.7%
    PRS 25.2%
  • basal cell CL0000646
    CSI 3.0
    rCSI 4.0%
    PRS 41.4%
  • mature astrocyte CL0002627
    CSI 3.0
    rCSI 12.7%
    PRS 38.1%
  • myeloid leukocyte CL0000766
    CSI 3.0
    rCSI 2.8%
    PRS 40.7%
  • tracheobronchial smooth muscle cell CL0019019
    CSI 3.0
    rCSI 5.3%
    PRS 47.9%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 3.0
    rCSI 4.3%
    PRS 37.1%
  • respiratory basal cell CL0002633
    CSI 3.1
    rCSI 3.2%
    PRS 45.1%
  • renal interstitial pericyte CL1001318
    CSI 3.1
    rCSI 8.5%
    PRS 36.9%
  • squamous epithelial cell CL0000076
    CSI 3.1
    rCSI 7.3%
    PRS 45.4%
  • regulatory T cell CL0000815
    CSI 3.1
    rCSI 3.6%
    PRS 63.4%
  • lung pericyte CL0009089
    CSI 3.1
    rCSI 8.3%
    PRS 46.6%
  • T-helper 17 cell CL0000899
    CSI 3.3
    rCSI 2.6%
    PRS 61.0%
  • intestine goblet cell CL0019031
    CSI 3.3
    rCSI 2.9%
    PRS 38.9%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [FOXO1](/details-gene/2308) (forkhead box O1) is a protein-coding gene located on chromosome 13q14.11 that encodes a member of the forkhead box (FOX) family of transcription factors. As a critical downstream effector of the insulin and PI3K-AKT signaling pathways, [FOXO1](/details-gene/2308) functions as a key regulator of a diverse array of cellular processes, including metabolism, apoptosis, cell cycle progression, and oxidative stress response. Its expression profile is widespread, showing high significance in metabolically active cells such as [adipocytes](/details-cell/CL0000136), as well as in various neuronal, endothelial, and immune cell populations. Chromosomal translocations involving this gene are associated with alveolar rhabdomyosarcoma ([OMIM:268220](https://omim.org/entry/268220)), highlighting its importance in both normal physiology and disease. ## Cellular Roles and Expression Landscape The expression pattern of [FOXO1](/details-gene/2308) suggests a foundational role across multiple, distinct physiological systems. **Overall**, the gene exhibits its highest significance in [adipocytes](/details-cell/CL0000136) (CSI: 70.71), underscoring its critical function in metabolic regulation and [Fat cell differentiation](/details-cell/GO:0045444). Beyond its metabolic role, [FOXO1](/details-gene/2308) is also highly significant in the nervous system. It is a key marker for [cardiac neurons](/details-cell/CL0010022) (CSI: 30.40) and several subtypes of cortical interneurons, including [sncg GABAergic cortical interneurons](/details-cell/CL4023015) and [sst GABAergic cortical interneurons](/details-cell/CL4023017), as well as [astrocytes of the cerebral cortex](/details-cell/CL0002605). This is consistent with its involvement in pathways regulating oxidative stress and neuronal maintenance. Furthermore, [FOXO1](/details-gene/2308) demonstrates notable significance within the immune system, particularly in lymphocyte populations such as [central memory CD8-positive, alpha-beta T cells](/details-cell/CL0000907) and [immature B cells](/details-cell/CL0000816). This expression aligns with its function in [Cytokine signaling in immune system](/details-pathway/R-HSA-1280215) and regulating lymphocyte survival and differentiation. The gene also shows relevance in structural and vascular cells, including [chondrocytes](/details-cell/CL0000138) and endothelial cells of the brain and lung, suggesting its participation in tissue homeostasis and development. The broad yet distinct cellular landscape of [FOXO1](/details-gene/2308) expression highlights its role as a versatile transcriptional hub integrating signals related to metabolism, stress, and cell fate across diverse tissues. ## Pathways and Molecular Function [FOXO1](/details-gene/2308) functions primarily as a [Dna-binding transcription factor activity, rna polymerase ii-specific](/details-pathway/GO:0000981) that can both activate and repress gene expression. Its activity is tightly controlled by post-translational modifications, particularly phosphorylation by kinases such as AKT ([Link](https://doi.org/10.1074/jbc.274.24.17179)), which promotes its exclusion from the [Nucleus](/details-pathway/GO:0005634) and subsequent inactivation ([Link](https://doi.org/10.1093/emboj/21.9.2263)). This mechanism is a central node in the [Insulin receptor signaling pathway](/details-pathway/GO:0008286) and is detailed in Reactome pathways like [Akt-mediated inactivation of foxo1a](/details-pathway/R-HSA-211163) and [PIP3 activates AKT signaling](/details-pathway/R-HSA-1257604). The transcriptional targets of [FOXO1](/details-gene/2308) are extensive, mediating its pleiotropic functions. Its involvement in [FOXO-mediated transcription](/details-pathway/R-HSA-9614085) governs several key cellular outcomes. For instance, it promotes the expression of genes involved in the [Apoptotic process](/details-pathway/GO:0006915) and [Autophagy](/details-pathway/GO:0006914), acting as a crucial checkpoint in response to cellular stress or growth factor withdrawal. Conversely, it also plays a vital role in metabolic homeostasis by driving [Positive regulation of gluconeogenesis](/details-pathway/GO:0045722) and responding to nutrient availability ([Cellular response to starvation](/details-pathway/GO:0009267)). In the context of the immune system, its activity is linked to [Signaling by interleukins](/details-pathway/R-HSA-449147), influencing lymphocyte development and function. Other regulatory mechanisms, such as acetylation by p300 ([Link](https://doi.org/10.1210/me.2004-0292)) and deacetylation by SIRT1 ([Link](https://doi.org/10.1073/pnas.0400593101)), further fine-tune its transcriptional output. ## Research Directions The widespread and context-specific functions of [FOXO1](/details-gene/2308) present several avenues for future research. Its role as a central integrator of metabolic and stress signals makes it a compelling subject for studies on aging, metabolic disease, and cancer. **Proposed Hypotheses:** 1. Given its paramount significance in [adipocytes](/details-cell/CL0000136) and its established role in insulin signaling, dysregulation of [FOXO1](/details-gene/2308) activity in these cells is a primary driver of insulin resistance. Hyper-activation of the PI3K-AKT pathway in obesity may lead to chronic nuclear exclusion of [FOXO1](/details-gene/2308), disrupting adipokine secretion and promoting a pro-inflammatory state. 2. The high significance of [FOXO1](/details-gene/2308) in diverse neuronal subtypes suggests it is a critical gatekeeper of neuronal health by managing oxidative stress. A decline in [FOXO1](/details-gene/2308) transcriptional activity with age could sensitize neurons to metabolic and oxidative damage, contributing to the pathology of neurodegenerative diseases. **Experimental Approach:** To test the first hypothesis, one could use an adipocyte-specific CRISPR-Cas9 mouse model to express a constitutively active (nuclear-localized) or dominant-negative mutant of [FOXO1](/details-gene/2308). Following a high-fat diet challenge, systemic glucose tolerance and insulin sensitivity could be measured. Concurrently, single-cell RNA sequencing (scRNA-seq) on the adipose tissue from these mice would reveal how specific [FOXO1](/details-gene/2308) activity states alter the transcriptional programs related to inflammation, lipid metabolism, and insulin signaling within adipocyte populations. **Therapeutic Potential:** [FOXO1](/details-gene/2308) itself is a challenging therapeutic target due to its role as a nuclear transcription factor and its broad expression. Direct inhibition or activation could lead to widespread, unpredictable side effects. A more viable strategy would be to target the upstream pathways that regulate its activity. For example, small molecule inhibitors of AKT or other upstream kinases could modulate [FOXO1](/details-gene/2308) function in diseases characterized by hyperactive PI3K-AKT signaling, such as certain cancers. In the specific case of alveolar rhabdomyosarcoma, targeting the aberrant activity of the PAX3-[FOXO1](/details-gene/2308) or PAX7-[FOXO1](/details-gene/2308) fusion proteins represents a clear, tumor-specific therapeutic opportunity. Thus, while systemic modulation of [FOXO1](/details-gene/2308) is likely problematic, strategies aimed at its upstream regulators or its pathological fusion products hold significant therapeutic promise.

Genular Protein ID: 2634259510

Symbol: FOXO1_HUMAN

Name: Forkhead box protein O1A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 8275086

Title: Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma.

PubMed ID: 8275086

DOI: 10.1038/ng1193-230

PubMed ID: 9479491

Title: Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily.

PubMed ID: 9479491

DOI: 10.1006/geno.1997.5122

PubMed ID: 15057823

Title: The DNA sequence and analysis of human chromosome 13.

PubMed ID: 15057823

DOI: 10.1038/nature02379

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 8187070

Title: Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.

PubMed ID: 8187070

PubMed ID: 10358075

Title: Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B.

PubMed ID: 10358075

DOI: 10.1074/jbc.274.24.17179

PubMed ID: 10358076

Title: Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.

PubMed ID: 10358076

DOI: 10.1074/jbc.274.24.17184

PubMed ID: 11311120

Title: The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.

PubMed ID: 11311120

DOI: 10.1042/bj3550597

PubMed ID: 11237865

Title: Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.

PubMed ID: 11237865

DOI: 10.1042/0264-6021:3540605

PubMed ID: 11980723

Title: Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion.

PubMed ID: 11980723

DOI: 10.1093/emboj/21.9.2263

PubMed ID: 12228231

Title: Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding.

PubMed ID: 12228231

DOI: 10.1074/jbc.m208063200

PubMed ID: 15220471

Title: Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity.

PubMed ID: 15220471

DOI: 10.1073/pnas.0400593101

PubMed ID: 15890677

Title: The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription.

PubMed ID: 15890677

DOI: 10.1210/me.2004-0292

PubMed ID: 15668399

Title: Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

PubMed ID: 15668399

DOI: 10.1073/pnas.0406789102

PubMed ID: 17024043

Title: Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection.

PubMed ID: 17024043

DOI: 10.1038/nature05288

PubMed ID: 18951090

Title: Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.

PubMed ID: 18951090

DOI: 10.1016/j.molcel.2008.09.013

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 18356527

Title: Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons.

PubMed ID: 18356527

DOI: 10.1126/science.1152337

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19483080

Title: C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1.

PubMed ID: 19483080

DOI: 10.1074/jbc.m109.017046

PubMed ID: 19221179

Title: Regulation of neuronal cell death by MST1-FOXO1 signaling.

PubMed ID: 19221179

DOI: 10.1074/jbc.m900461200

PubMed ID: 20543840

Title: Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.

PubMed ID: 20543840

DOI: 10.1038/ncb2069

PubMed ID: 20668652

Title: KRIT1 regulates the homeostasis of intracellular reactive oxygen species.

PubMed ID: 20668652

DOI: 10.1371/journal.pone.0011786

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21245099

Title: Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner.

PubMed ID: 21245099

DOI: 10.1158/0008-5472.can-10-2203

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 25009184

Title: Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.

PubMed ID: 25009184

DOI: 10.1073/pnas.1411026111

PubMed ID: 31063815

Title: Cyclophilin A-FoxO1 signaling pathway in endothelial cell apoptosis.

PubMed ID: 31063815

DOI: 10.1016/j.cellsig.2019.04.014

PubMed ID: 18786403

Title: Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification.

PubMed ID: 18786403

DOI: 10.1016/j.str.2008.06.013

Sequence Information:

  • Length: 655
  • Mass: 69662
  • Checksum: 6DEF6C994BDFDBAB
  • Sequence:
  • MAEAPQVVEI DPDFEPLPRP RSCTWPLPRP EFSQSNSATS SPAPSGSAAA NPDAAAGLPS 
    ASAAAVSADF MSNLSLLEES EDFPQAPGSV AAAVAAAAAA AATGGLCGDF QGPEAGCLHP 
    APPQPPPPGP LSQHPPVPPA AAGPLAGQPR KSSSSRRNAW GNLSYADLIT KAIESSAEKR 
    LTLSQIYEWM VKSVPYFKDK GDSNSSAGWK NSIRHNLSLH SKFIRVQNEG TGKSSWWMLN 
    PEGGKSGKSP RRRAASMDNN SKFAKSRSRA AKKKASLQSG QEGAGDSPGS QFSKWPASPG 
    SHSNDDFDNW STFRPRTSSN ASTISGRLSP IMTEQDDLGE GDVHSMVYPP SAAKMASTLP 
    SLSEISNPEN MENLLDNLNL LSSPTSLTVS TQSSPGTMMQ QTPCYSFAPP NTSLNSPSPN 
    YQKYTYGQSS MSPLPQMPIQ TLQDNKSSYG GMSQYNCAPG LLKELLTSDS PPHNDIMTPV 
    DPGVAQPNSR VLGQNVMMGP NSVMSTYGSQ ASHNKMMNPS SHTHPGHAQQ TSAVNGRPLP 
    HTVSTMPHTS GMNRLTQVKT PVQVPLPHPM QMSALGGYSS VSSCNGYGRM GLLHQEKLPS 
    DLDGMFIERL DCDMESIIRN DLMDGDTLDF NFDNVLPNQS FPHSVKTTTH SWVSG